Live from the NIH registry
Studies recruiting near Manchester right now
Top 25 of 89 recruiting studies, sorted by proximity — each links to its official registry page
SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)
Gastrointestinal Cancer, Hematologic Cancer
N/A
Interventional 210 participants sought
Dana-Farber Cancer Instiute - Merrimack Valley — Methuen, Massachusetts (22.0 mi)
· Sponsor: Nadine McCleary, MD, MPH
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
Diabetes Mellitus, Hypertension
N/A
Interventional 1,022 participants sought
Dartmouth Hitchcock Clinics Manchester — Manchester, New Hampshire (0.9 mi)
· Sponsor: Dartmouth-Hitchcock Medical Center
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
Growth Hormone Deficiency
N/A
Observational 500 participants sought
Ascendis Investigational Site — Manchester, New Hampshire (0.9 mi)
· Sponsor: Ascendis Pharma Endocrinology Division A/S
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
Advanced Cancer, Metastatic Cancer
N/A
Interventional 1,000 participants sought
Solinsky Center for Cancer Care — Manchester, New Hampshire (0.9 mi)
· Sponsor: Alliance Foundation Trials, LLC.
The CONFORM Pivotal Trial
Atrial Fibrillation, Stroke
N/A
Interventional 1,600 participants sought
Catholic Medical Center — Manchester, New Hampshire (0.9 mi)
· Sponsor: Conformal Medical, Inc
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
Growth Hormone Deficiency
N/A
Observational 900 participants sought
Ascendis Investigational Site — Manchester, New Hampshire (0.9 mi)
· Sponsor: Ascendis Pharma Endocrinology Division A/S
Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients
Anxiety Disorders, Depression Disorders
N/A
Interventional 2,448 participants sought
Dartmouth Hitchcock Manchester Family Practice — Manchester, New Hampshire (0.9 mi)
· Sponsor: Dartmouth-Hitchcock Medical Center
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 474 participants sought
Dana Farber-Merrimack Valley — Methuen, Massachusetts (22.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Regulation of Emotion, Sleep Extension, and mTBI
Mild Traumatic Brain Injury
Phase 1
Interventional 60 participants sought
Merrimack College — North Andover, Massachusetts (25.2 mi)
· Sponsor: Merrimack College
The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults
Insulin Resistance, Impaired Glucose Tolerance
N/A
Interventional 45 participants sought
University of New Hampshire Cardiometabolic Research Laboratory — Durham, New Hampshire (28.1 mi)
· Sponsor: University of New Hampshire
Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy
Allergic Conjunctivitis
Phase 3
Interventional 350 participants sought
Andover Eye Associates — Andover, Massachusetts (27.4 mi)
· Sponsor: Regeneron Pharmaceuticals
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Solinsky Center for Cancer Care — Manchester, New Hampshire (0.9 mi)
· Sponsor: NRG Oncology
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Age-Related Macular Degeneration, Geographic Atrophy
N/A
Interventional 125 participants sought
Tallman Eye Associates — Lawrence, Massachusetts (23.9 mi)
· Sponsor: VisionCare, Inc.
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
Breast Cancer, Cognitive Impairments
N/A
Interventional 386 participants sought
Saint Joseph Hospital — Nashua, New Hampshire (15.2 mi)
· Sponsor: NRG Oncology
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Extensive Stage Lung Small Cell Carcinoma
Phase 2, Phase 3
Interventional 138 participants sought
Lowell General Hospital — Lowell, Massachusetts (25.1 mi)
· Sponsor: National Cancer Institute (NCI)
Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome, Respiratory Failure
Phase 3
Interventional 1,100 participants sought
Lowell General Hospital — Lowell, Massachusetts (25.1 mi)
· Sponsor: Beth Israel Deaconess Medical Center
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
Elliot Hospital — Manchester, New Hampshire (0.9 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Phase 3
Interventional 4,220 participants sought
Dana Farber Cancer Institute - Merrimack Valley — Methuen, Massachusetts (22.0 mi)
· Sponsor: Stemline Therapeutics, Inc.
I-DECIDE After Bronchiolitis Hospitalization
Bronchiolitis Acute
N/A
Interventional 2,700 participants sought
Children's Hospital at Dartmouth-Hitchcock — Manchester, New Hampshire (0.9 mi)
· Sponsor: Seattle Children's Hospital
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
Solinsky Center for Cancer Care — Manchester, New Hampshire (0.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Solinsky Center for Cancer Care — Manchester, New Hampshire (0.9 mi)
· Sponsor: SWOG Cancer Research Network
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8
Phase 3
Interventional 304 participants sought
The Dana-Farber Cancer Institute at Londonderry — Londonderry, New Hampshire (9.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Osteoarthritis, Knee, Diabetic Neuropathic Pain
Phase 2
Interventional 10,000 participants sought
ActivMed Practices and Research — Methuen, Massachusetts (22.0 mi)
· Sponsor: Eli Lilly and Company
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,000 participants sought
Solinsky Center for Cancer Care — Manchester, New Hampshire (0.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Healthy Perspectives - Innovate Mental Health Services /ID# 270847 — Nashua, New Hampshire (15.2 mi)
· Sponsor: AbbVie